Rein Therapeutics Inc (RNTX) — Financial Flexibility Index
Rein Therapeutics Inc (RNTX) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of $-3.55 Million (operating CF $-3.55 Million minus capex $0.00) represents 0% of total liabilities ($7.52 Million). Also explore Rein Therapeutics Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Rein Therapeutics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Rein Therapeutics Inc across 10 annual periods. Check how resilient are Rein Therapeutics Inc's assets to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Rein Therapeutics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Rein Therapeutics Inc. For the full company profile including market capitalisation, see RNTX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.50x | $-22.29 Million | $-22.29 Million | $14.85 Million | ▼ -651.3% |
| 2023 | -0.20x | $-19.81 Million | $-19.81 Million | $99.12 Million | ▲ +97.3% |
| 2022 | -7.35x | $-24.86 Million | $-24.86 Million | $3.38 Million | ▼ -42.5% |
| 2021 | -5.16x | $-23.60 Million | $-23.75 Million | $4.58 Million | ▼ -5.2% |
| 2020 | -4.90x | $-20.47 Million | $-20.48 Million | $4.18 Million | ▼ -94.0% |
| 2019 | -2.52x | $-26.32 Million | $-26.47 Million | $10.43 Million | ▼ -15.1% |
| 2018 | -2.19x | $-23.50 Million | $-27.93 Million | $10.71 Million | ▲ +47.4% |
| 2017 | -4.17x | $-20.39 Million | $-20.53 Million | $4.89 Million | ▼ -3615.7% |
| 2016 | -0.11x | $-15.01 Million | $-15.01 Million | $133.83 Million | ▲ +3.2% |
| 2015 | -0.12x | $-11.62 Million | $-11.71 Million | $100.26 Million | — |